350 related articles for article (PubMed ID: 29878355)
1. Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by the resectability status.
Kondo N; Murakami Y; Uemura K; Nakagawa N; Okada K; Takahashi S; Sueda T
J Surg Oncol; 2018 Dec; 118(7):1105-1114. PubMed ID: 29878355
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of the validity of surgery for patients with pancreatic cancer aged 80 years or older stratified by resectability status.
Kondo N; Uemura K; Nakagawa N; Okada K; Seo S; Takahashi S; Murakami Y
J Hepatobiliary Pancreat Sci; 2020 Feb; 27(2):64-74. PubMed ID: 31602815
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
[TBL] [Abstract][Full Text] [Related]
4. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
5. Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity.
De Reuver PR; Mittal A; Neale M; Gill AJ; Samra JS
Surgery; 2015 Jul; 158(1):183-90. PubMed ID: 25920909
[TBL] [Abstract][Full Text] [Related]
6. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
7. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
[TBL] [Abstract][Full Text] [Related]
8. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.
Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368
[TBL] [Abstract][Full Text] [Related]
9. Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.
Sauvanet A; Boher JM; Paye F; Bachellier P; Sa Cuhna A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
J Am Coll Surg; 2015 Aug; 221(2):380-9. PubMed ID: 26206638
[TBL] [Abstract][Full Text] [Related]
10. Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Khachfe HH; Hammad AY; AlMasri S; Nassour I; ElAsmar R; Liu H; de Silva A; Kraftician J; Lee KK; Zureikat AH; Paniccia A
J Surg Oncol; 2024 May; 129(6):1097-1105. PubMed ID: 38316936
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
[TBL] [Abstract][Full Text] [Related]
12. Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.
Kim Y; Kim SC; Song KB; Kim J; Kang DR; Lee JH; Park KM; Lee YJ
HPB (Oxford); 2016 Apr; 18(4):325-31. PubMed ID: 27037201
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of pancreatic fistula and postoperative complications after pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma.
Neeman U; Lahat G; Goykhman Y; Geva R; Peles-Avraham S; Nachmany I; Nakache R; Klausner JM; Lubezky N
Surgeon; 2020 Feb; 18(1):24-30. PubMed ID: 31466841
[TBL] [Abstract][Full Text] [Related]
14. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
[TBL] [Abstract][Full Text] [Related]
15. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH
Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381
[TBL] [Abstract][Full Text] [Related]
16. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer.
Kato Y; Yamada S; Tashiro M; Sonohara F; Takami H; Hayashi M; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kodera Y
HPB (Oxford); 2019 Sep; 21(9):1211-1218. PubMed ID: 30773450
[TBL] [Abstract][Full Text] [Related]
17. Serious complications of pancreatoduodenectomy correlate with lower rates of adjuvant chemotherapy: Results from the recurrence after Whipple's (RAW) study.
Russell TB; Labib PL; Ausania F; Pando E; Roberts KJ; Kausar A; Mavroeidis VK; Marangoni G; Thomasset SC; Frampton AE; Lykoudis P; Maglione M; Alhaboob N; Bari H; Smith AM; Spalding D; Srinivasan P; Davidson BR; Bhogal RH; Croagh D; Dominguez I; Thakkar R; Gomez D; Silva MA; Lapolla P; Mingoli A; Porcu A; Shah NS; Hamady ZZR; Al-Sarrieh B; Serrablo A; ; ; ; ; ; ; ; ; Aroori S
Eur J Surg Oncol; 2023 Sep; 49(9):106919. PubMed ID: 37330348
[TBL] [Abstract][Full Text] [Related]
18. Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yamaue H
Eur J Surg Oncol; 2021 Oct; 47(10):2586-2594. PubMed ID: 34127329
[TBL] [Abstract][Full Text] [Related]
19. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy.
Roland CL; Katz MH; Tzeng CW; Lin H; Varadhachary GR; Shroff R; Javle M; Fogelman D; Wolff RA; Vauthey JN; Crane CH; Lee JE; Fleming JB
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1221-8. PubMed ID: 26350371
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Resectability Status.
Sakoda T; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Takahashi S
J Gastrointest Surg; 2021 Nov; 25(11):2871-2880. PubMed ID: 33768425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
